Archeus Technologies has received FDA clearance for its Investigational New Drug (IND) application for ART-101, a novel receptor-based targeting small molecule developed for the imaging and treatment of prostate cancer,…

Archeus Technologies, a company developing multiple differentiated radiopharmaceutical therapies, and the Wisconsin Alumni Research Foundation (WARF) have entered into a strategic collaboration to advance ART-101, a receptor-based targeting molecule, into…

Phoenix has been awarded a $10 million indefinite quantity, indefinite delivery (IDIQ) contract with the U.S. Army, the company announced today. According to a release, the contract will demonstrate improved…

Phoenix, LLC, unveiled its Phoenix Neutron Imaging Center (PNIC), located in the Uptown neighborhood on the east side of Fitchburg, Wis., last Friday. According to a release, the PNIC is the…

Phoenix has secured $4 million in funding from the U.S. Army to demonstrate neutron-based methods of nondestructive testing, the company announced today. “With N-ray and X-ray capabilities merged, the technology Phoenix…

Phoenix, which designs and manufactures the world’s strongest neutron generators, is building a neutron imaging center in Fitchburg, Wis., the company announced recently. According to a release, the 10,000-square foot building,…